Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA)-Reference-Cited by-同舟云学术

Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA)

Published:2024-02-15 Issue:2 Volume:205 Page:211-226
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Gao Lucy,Medford Arielle,Spring Laura,Bar Yael,Hu Bonnie,Jimenez Rachel,Isakoff Steven J.,Bardia Aditya,Peppercorn Jeffrey^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10549-024-07253-6.pdf

Reference148 articles.

1. Ahmad A (2019) Breast cancer statistics: recent trends. Adv Exp Med Biol 1152:1–7. https://doi.org/10.1007/978-3-030-20301-6_1

2. Pedersen RN, Esen BO, Mellemkjaer L, Christiansen P, Ejlertsen B, Lash TL, Norgaard M, Cronin-Fenton D (2022) The incidence of breast cancer recurrence 10–32 years after primary diagnosis. J Natl Cancer Inst 114:391–399. https://doi.org/10.1093/jnci/djab202

3. Tewari A, Chagpar AB (2014) Worry about breast cancer recurrence: a population-based analysis. Am Surg 80:640–645

4. Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, Perou CM, Regan MM, Rimm DL, Symmans WF, Torlakovic EE, Varella L, Viale G, Weisberg TF, McShane LM, Wolff AC (2020) Estrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. J Clin Oncol 38:1346–1366. https://doi.org/10.1200/JCO.19.02309

5. Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JM, Bilous M, Ellis IO, Fitzgibbons P, Hanna W (2018) Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update. Arch Pathol Lab Med 142:1364–1382

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of Bioinformatics and Machine Learning to Identify CD8+ T Cell-Related Prognostic Signature to Predict Clinical Outcomes and Treatment Response in Breast Cancer Patients;Genes;2024-08-19

2. Circulating Tumor DNA for Solid Tumor Minimal/Molecular Residual Disease Detection in Cancer Survivors;The American Journal of Medicine;2024-08

3. Circulating biomarkers for diagnosis and response to therapies in cancer patients;International Review of Cell and Molecular Biology;2024